| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/23/2001 | WO2001060820A2 Matrix metalloproteinase inhibitors and uses thereof |
| 08/23/2001 | WO2001060817A1 Process for the preparation of (pyridinylidene)-phthalides |
| 08/23/2001 | WO2001060816A1 Kinase inhibitors |
| 08/23/2001 | WO2001060814A2 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/23/2001 | WO2001060813A1 Beta-alanine derivatives and their use as receptor antagonists |
| 08/23/2001 | WO2001060806A2 Substituted arylpyrazines |
| 08/23/2001 | WO2001060805A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 08/23/2001 | WO2001060803A1 Fused imidazolium derivatives |
| 08/23/2001 | WO2001060802A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use as alpha-1a agonists |
| 08/23/2001 | WO2001060369A1 Inhibitors of prenyl-protein transferase |
| 08/23/2001 | WO2001060368A1 Inhibitors of prenyl-protein transferase |
| 08/23/2001 | WO2001010860A3 Quinazolinone and azaquinazolinone derivatives |
| 08/23/2001 | WO2001007436A3 Substituted oxoazaheterocyclyl compounds |
| 08/23/2001 | WO2001004116A3 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
| 08/23/2001 | WO2000071508A3 Inhibitors of factor Xa |
| 08/23/2001 | US20010016659 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/23/2001 | US20010016657 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 08/23/2001 | US20010016588 Antiallergens; antitumor agents; anticancer agents |
| 08/23/2001 | US20010016585 Antitumor agent |
| 08/23/2001 | US20010016583 Therapeutic application of pro-apoptotic benzodiazepines |
| 08/23/2001 | US20010016570 Bone disorders |
| 08/23/2001 | CA2651825A1 Substituted arylpyrazines |
| 08/23/2001 | CA2400631A1 Beta-alanine derivatives and their use as receptor antagonists |
| 08/23/2001 | CA2399147A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use as alpha-1a agonists |
| 08/23/2001 | CA2398937A1 Substituted arylpyrazines |
| 08/23/2001 | CA2395862A1 Succinoylamino carbocycles and heterocycles as inhibitors of a.beta. protein production |
| 08/23/2001 | CA2395841A1 Matrix metalloproteinase inhibitors and uses thereof |
| 08/22/2001 | EP1125929A1 Method for making (-)-(2R,4S)-4-[(3,5-bis-trifluoromethyl-benzyl)-methoxycarbonylamino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester |
| 08/22/2001 | EP1125924A1 Intermediate for the synthesis of amlodipine, preparation process and corresponding utilization |
| 08/22/2001 | EP1125580A2 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
| 08/22/2001 | EP1124823A1 Thrombin inhibitors |
| 08/22/2001 | EP1124822A1 Thrombin inhibitors |
| 08/22/2001 | EP1124821A1 Compounds |
| 08/22/2001 | EP1124809A1 Benzoylpyridazines |
| 08/22/2001 | EP1124804A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 08/22/2001 | EP1124539A1 Pharmaceutical formulation comprising omeprazole |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/22/2001 | EP0799210B1 Piperazine-2,5-dione derivatives as modulators of multidrug resistance |
| 08/22/2001 | EP0777653B1 Dihygropyridine derivatives as bradykinin antagonists |
| 08/22/2001 | EP0752854B1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments |
| 08/22/2001 | CN1309656A Thioalkyl alpha-substd. pyrimidine compounds |
| 08/22/2001 | CN1309654A Biphenyl derivs. |
| 08/22/2001 | CN1309648A Piperazinone derivs. and their uses |
| 08/22/2001 | CN1309639A Pharmaceutical compositions comprising 2-quinolones |
| 08/22/2001 | CN1309638A N-substd. naphthalene carboxamides as neurokinin-receptor antagonists |
| 08/22/2001 | CN1309325A Photographic element, compound and method |
| 08/22/2001 | CN1309123A Intermediate for preparing herbicidal 1-alkenyl tetrazolinone |
| 08/22/2001 | CN1069900C Pesticide |
| 08/21/2001 | US6277997 Hydrogenating asymmetrically 2,5-dihydrofuran derivative in presence of catalyst comprising metal diphosphine complex to produce lactone derivative |
| 08/21/2001 | US6277991 For treatment of migraine, non-insulin dependent diabetes mellitus, sepsis, inflammation, incontinence, vasomotor disturbances such as hot flushes or hot flashes |
| 08/21/2001 | US6277989 Quinazoline derivatives as medicaments |
| 08/21/2001 | US6277878 Substituted indole compounds as anti-inflammatory and analgesic agents |
| 08/21/2001 | US6277877 Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors |
| 08/21/2001 | US6277871 Inhibitors of protein isoprenyl transferases |
| 08/21/2001 | US6277865 Anticoagulants |
| 08/21/2001 | US6277859 Highly selective kappa-opioid agonists useful as analgesics and diuretics with reduced physiological side effects |
| 08/21/2001 | US6277855 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
| 08/21/2001 | US6277854 For treatment of tumor cells expressing an activated ras oncogene |
| 08/21/2001 | US6277853 Indole derivatives as 5-HT1B and 5-HT1D agonists |
| 08/21/2001 | US6277840 Antiinflammatory agents |
| 08/21/2001 | US6277789 Substituted phenyluracils |
| 08/21/2001 | CA2083606C Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
| 08/21/2001 | CA2026143C Triazole compounds, their production and use |
| 08/16/2001 | WO2001058899A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 08/16/2001 | WO2001058893A2 Indol-3-yl derivatives and their use as integrin inhibitors |
| 08/16/2001 | WO2001058892A1 Tyrosine derivatives with anti-leukotriene activity |
| 08/16/2001 | WO2001058891A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 08/16/2001 | WO2001058881A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 08/16/2001 | WO2001058876A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient |
| 08/16/2001 | WO2001058873A1 Method for producing 5-aryl nicotinaldehydes |
| 08/16/2001 | WO2001058869A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 08/16/2001 | WO2001058853A1 Dehydroamino acids |
| 08/16/2001 | WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 08/16/2001 | WO2001010381A3 Methods for treating or preventing pain and anxiety |
| 08/16/2001 | WO2001010380A3 Benzanilides as potassium channel openers |
| 08/16/2001 | WO2001009119A3 Chemokine receptor antagonists |
| 08/16/2001 | WO2001009096A3 Potassium channel openers |
| 08/16/2001 | WO2000066106A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | WO2000015212A3 Antifungal activity of dicationic molecules |
| 08/16/2001 | US20010014740 Method of producing heterocyclic derivatives |
| 08/16/2001 | US20010014737 Antiinflammatory agents, cardiovascualr disorders, osteoporosis, anticancer agents |
| 08/16/2001 | US20010014690 Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor action |
| 08/16/2001 | US20010014689 Nervous system disorders |
| 08/16/2001 | US20010014688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 08/16/2001 | US20010014683 Analgesics; side effect reduction |
| 08/16/2001 | US20010014681 Compounds useful for inhibition of farnesyl protein transferase |
| 08/16/2001 | US20010014680 1,4-piperazine derivatives |
| 08/16/2001 | EP1143946A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | EP1123932A1 Novel anthrapyridone compounds, water-based magenta ink composition, and method of ink-jet printing |
| 08/16/2001 | EP1123931A1 Tricylic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 08/16/2001 | EP1123925A1 Process for preparation of substituted pyridines |
| 08/16/2001 | EP1123924A1 Substituted pyridines as HMG-COA reductase inhibitors |
| 08/16/2001 | EP1123918A1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 08/16/2001 | EP1123704A1 Remedies for spinal canal stenosis |
| 08/16/2001 | EP1123296A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 08/16/2001 | EP1123288A1 Vitreous form of known bradykinin antagonist |
| 08/16/2001 | EP1123287A1 Insecticidal 3- (substituted pyridyl) -1, 2, 4-triazoles |
| 08/16/2001 | EP1123285A1 Substituted benzopyran analogs for the treatment of inflammation |
| 08/16/2001 | EP1123280A1 Serine protease inhibitor |
| 08/16/2001 | EP1123277A1 Epibatidine analogues as acetylcholine receptor antagonists |